Mexedia SpA SB
PAR:ALMEX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.2
20.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ALMEX stock under the Base Case scenario is 35.35 EUR. Compared to the current market price of 6.7 EUR, Mexedia SpA SB is Undervalued by 81%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Mexedia SpA SB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for ALMEX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Mexedia SpA SB
Balance Sheet Decomposition
Mexedia SpA SB
Current Assets | 41.6m |
Cash & Short-Term Investments | 2.7m |
Receivables | 38.9m |
Non-Current Assets | 55.4m |
Long-Term Investments | 125k |
PP&E | 73k |
Intangibles | 55.1m |
Other Non-Current Assets | 10k |
Current Liabilities | 34.2m |
Accounts Payable | 4.1m |
Short-Term Debt | 29m |
Other Current Liabilities | 1m |
Non-Current Liabilities | 62k |
Other Non-Current Liabilities | 62k |
Earnings Waterfall
Mexedia SpA SB
Revenue
|
140.9m
EUR
|
Cost of Revenue
|
-129.1m
EUR
|
Gross Profit
|
11.8m
EUR
|
Operating Expenses
|
-3.5m
EUR
|
Operating Income
|
8.4m
EUR
|
Other Expenses
|
-3.9m
EUR
|
Net Income
|
4.4m
EUR
|
Free Cash Flow Analysis
Mexedia SpA SB
EUR | |
Free Cash Flow | EUR |
ALMEX Profitability Score
Profitability Due Diligence
Mexedia SpA SB's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Mexedia SpA SB's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
ALMEX Solvency Score
Solvency Due Diligence
Mexedia SpA SB's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Mexedia SpA SB's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALMEX Price Targets Summary
Mexedia SpA SB
According to Wall Street analysts, the average 1-year price target for ALMEX is 36.21 EUR with a low forecast of 35.35 EUR and a high forecast of 37.8 EUR.
Dividends
Current shareholder yield for ALMEX is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Mexedia SpA is an equity investments company, which engages in the wholesale telecommunications services and liquidity pool, operating an all-in-one B2B voice and SMS trading solution with fintech modules enabling direct bank account integration and receivables auctioning. The company is headquartered in Rome, Roma and currently employs 4 full-time employees. The company went IPO on 2021-09-22. The firm promotes, designs, develops and implements investment plans and programs. The company contracts mortgages and loans and provides guarantees, including debts contracted by third parties. The firm operates globally.
Officers
The intrinsic value of one ALMEX stock under the Base Case scenario is 35.35 EUR.
Compared to the current market price of 6.7 EUR, Mexedia SpA SB is Undervalued by 81%.